Nationwide analysis examines mortality trends from cancer, cardiovascular disease, and venous thromboembolism in older PE patients, suggesting important shifts over time.
Key Points
Cancer was the leading cause of 30-day mortality in PE patients aged ≥50 years, remaining stable from 2006 to 2023.
Mortality from fatal venous thromboembolism decreased significantly from 2.7% to 1.3%, indicating improved outcomes.
Cardiovascular disease-related mortality also declined from 2.3% to 1.1%, showing positive trends for older PE patients.
Subgroup analysis revealed a contrasting trend in cancer mortality between PE patients with and without known cancer.